Patent · US Active

Pyrrolo-triazine aniline compounds useful as kinase inhibitors

US7462616B2 · kind B2 · utility

5Cited by

7References

13Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Alaric J. Dyckman · Lawrenceville, US
John Hynes · Washington Crossing, US
Katerina Leftheris · Skillman, US
Chunjian Liu · Pennington, US
Stephen T. Wrobleski · Whitehouse Station, US

Key dates

Filing date	Oct 24, 2006
Grant date	Dec 9, 2008
Priority date	—
Expiry date	Oct 24, 2026

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds having the formula (I),and pharmaceutically acceptable salts, prodrugs, and solvates thereof, are useful as kinase inhibitors, wherein R1, R2, R3, R4, R5, R6, X and Z are as described in the specification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.